Title:
注射用ボツリヌス毒素製剤
Document Type and Number:
Japanese Patent JP6976997
Kind Code:
B2
Abstract:
This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.
Inventors:
Ruegg Curtis El.
Stone Hong Gran F.
War Jacob M.
Stone Hong Gran F.
War Jacob M.
Application Number:
JP2019131603A
Publication Date:
December 08, 2021
Filing Date:
July 17, 2019
Export Citation:
Assignee:
REVANCE THERAPEUTICS,INC.
International Classes:
A61K35/74; A61K9/08; A61K9/19; A61K47/42; A61P11/02; A61P13/10; A61P17/00; A61P17/10; A61P17/16; A61P21/02; A61P25/04; A61P25/06; A61P29/00; A61P37/04
Domestic Patent References:
| JP5866202B2 | ||||
| JP2004513075A | ||||
| JP2007526340A | ||||
| JP2008531725A |
Foreign References:
| WO2008082889A1 |
Attorney, Agent or Firm:
Masaki Hirota
Seiji Ozawa
Yusaku Tokai
Makoto Horiuchi
Masako Yamauchi
Shuichi Sonomoto
Seiji Ozawa
Yusaku Tokai
Makoto Horiuchi
Masako Yamauchi
Shuichi Sonomoto
Previous Patent: Dynamic story-oriented digital language education methods and systems
Next Patent: Optical system and image pickup device
Next Patent: Optical system and image pickup device